Virus Infections and Host Metabolism—Can We Manage the Interactions?
Abstract
When viruses infect cells, they almost invariably cause metabolic changes in the infected cell as well as in several host cell types that react to the infection. Such metabolic changes provide potential targets for therapeutic approaches that could reduce the impact of infection. Several examples are discussed in this review, which include effects on energy metabolism, glutaminolysis and fatty acid metabolism. The response of the immune system also involves metabolic changes and manipulating these may change the outcome of infection. This could include changing the status of herpesviruses infections from productive to latency. The consequences of viral infections which include coronavirus disease 2019 (COVID-19), may also differ in patients with metabolic problems, such as diabetes mellitus (DM), obesity, and endocrine diseases. Nutrition status may also affect the pattern of events following viral infection and examples that impact on the pattern of human and experimental animal viral diseases and the mechanisms involved are discussed. Finally, we discuss the so far few published reports that have manipulated metabolic events in-vivo to change the outcome of virus infection. The topic is expected to expand in relevance as an approach used alone or in combination with other therapies to shape the nature of virus induced diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The significant shift in glucose consumption following viral infection highlights profound metabolic changes induced in host cells.
“The significant shift in glucose consumption following viral infection highlights the profound metabolic changes induced in host cells [31].”
From Mechanistic model for HEK293 viral vector processes and its application in a digital shadow framework (2026) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254 · see citing works
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · see citing works
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 1× · see citing works
“The protein component of COVID-19 that binds ACE2 is the spike protein and soluble forms of ACE2 can block virus infection (93, 94).”
BackgroundThyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421 · see citing works
Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment
Naveiras, O., Nardi, V., Wenzel, P. L., Hauschka, P. V., Fahey, F., & Daley, G. Q. (2009) · Nature · doi:10.1038/nature08099 · Cited by 1,129 · see citing works
Bachem, A., Makhlouf, C., Binger, K. J., de Souza, D. P., Tull, D., Hochheiser, K., Whitney, P. G., Fernandez-Ruiz, D., Dähling, S., Kastenmüller, W., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.002 · Cited by 702 · see citing works
Flagged first, then by citations
Research works printed but not linked: 165
- [1]Alcami A Koszinowski UH Viral mechanisms of immune evasion. Trends Microbiol (2000) 8: 410–8. 10.1016/S0966-842X(00)01830-8 PMC7141568 10989308 · DOI
- [2]Rouse BT Sehrawat S Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol (2010) 10: 514–26. 10.1038/nri2802 PMC3899649 20577268 · DOI
- [3]Sumbria D Berber E Rouse BT Factors affecting the tissue damaging consequences of viral infections. Front Microbiol (2019) 10: 2314. 10.3389/fmicb.2019.02314 31636623 PMC6787772 · DOI
- [4]Wu D Sanin David E Everts B Chen Q Qiu J Buck Michael D Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function. Immunity (2016) 44: 1325–36. 10.1016/j.immuni.2016.06.006 PMC5695232 27332732 · DOI
- [5]Apicella M Campopiano MC Mantuano M Mazoni L Coppelli A Del Prato S COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol (2020) 8: 782–92. 10.1016/S2213-8587(20)30238-2 PMC7367664 32687793 · DOI
- [6]Smith M Honce R Schultz-Cherry S Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses. J Virol (2020) 94: e00665–00620. 10.1128/JVI.00665-20 PMC7459568 32661141 · DOI
- [7]Ikeda M Kato N Modulation of host metabolism as a target of new antivirals. Adv Drug Delivery Rev (2007) 59: 1277–89. 10.1016/j.addr.2007.03.021 PMC7103349 17897752 · DOI
- [8]Varanasi SK Rouse BT How host metabolism impacts on virus pathogenesis. Curr Opin Virol (2018) 28: 37– 42. 10.1016/j.coviro.2017.11.003 29156318 · DOI
- [9]Thai M Graham Nicholas A Braas D Nehil M Komisopoulou E Kurdistani Siavash K Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication. Cell Metab (2014) 19: 694– 701. 10.1016/j.cmet.2014.03.009 24703700 PMC4294542 · DOI
- [10]Munger J Bennett BD Parikh A Feng X-J McArdle J Rabitz HA Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol (2008) 26: 1179–86. 10.1038/nbt.1500 PMC2825756 18820684 · DOI
- [11]Xiao L Zy H Dong X Tan Z Li W Tang M Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene (2014) 33: 4568–78. 10.1038/onc.2014.32 PMC4162460 24662831 · DOI
- [12]Bhatt AP Jacobs SR Freemerman AJ Makowski L Rathmell JC Dittmer DP Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci USA (2012) 109: 11818–23. 10.1073/pnas.1205995109 PMC3406848 22752304 · DOI
- [13]Ripoli M D’Aprile A Quarato G Sarasin-Filipowicz M Gouttenoire J Scrima R Hepatitis C Virus-Linked Mitochondrial Dysfunction Promotes Hypoxia-Inducible Factor 1α-Mediated Glycolytic Adaptation. J Virol (2010) 84: 647–60. 10.1128/jvi.00769-09 PMC2798449 19846525 · DOI
- [14]Hegedus A Kavanagh Williamson M Huthoff H HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells. Retrovirology (2014) 11: 98. 10.1186/s12977-014-0098-4 25421745 PMC4252996 · DOI
- [15]Fontaine KA Sanchez EL Camarda R Lagunoff M Dengue virus induces and requires glycolysis for optimal replication. J Virol (2015) 89: 2358–66. 10.1128/jvi.02309-14 PMC4338897 25505078 · DOI
- [16]Ritter JB Wahl AS Freund S Genzel Y Reichl U Metabolic effects of influenza virus infection in cultured animal cells: Intra- and extracellular metabolite profiling. BMC Syst Biol (2010) 4: 61. 10.1186/1752-0509-4-61 20465796 PMC2890500 · DOI
- [17]Chambers JW Maguire TG Alwine JC Glutamine metabolism is essential for human cytomegalovirus infection. J Virol (2010) 84: 1867–73. 10.1128/jvi.02123-09 PMC2812398 19939921 · DOI · Paper page
- [18]Sanchez EL Carroll PA Thalhofer AB Lagunoff M Latent KSHV infected endothelial cells are glutamine addicted and require glutaminolysis for survival. PLoS Pathog (2015) 11: e1005052. 10.1371/journal.ppat.1005052 26197457 PMC4510438 · DOI
- [19]Fontaine KA Camarda R Lagunoff M Vaccinia virus requires glutamine but not glucose for efficient replication. J Virol (2014) 88: 4366–74. 10.1128/jvi.03134-13 PMC3993723 24501408 · DOI
- [20]Kapadia SB Chisari FV Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA (2005) 102: 2561–6. 10.1073/pnas.0409834102 PMC549027 15699349 · DOI
- [21]Yang W Hood BL Chadwick SL Liu S Watkins SC Luo G Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology (2008) 48: 1396–403. 10.1002/hep.22508 PMC2614928 18830996 · DOI
- [22]Heaton NS Perera R Berger KL Khadka S LaCount DJ Kuhn RJ Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci USA (2010) 107: 17345–50. 10.1073/pnas.1010811107 PMC2951450 20855599 · DOI · Paper page
- [23]Hollenbaugh JA Munger J Kim B Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC–MS/MS analysis. Virology (2011) 415: 153–9. 10.1016/j.virol.2011.04.007 PMC3107887 21565377 · DOI
- [24]Kang S Tang H HIV-1 infection and glucose metabolism reprogramming of T cells: another approach toward functional cure and reservoir eradication. Front Immunol (2020) 11: 572677. 10.3389/fimmu.2020.572677 33117366 PMC7575757 · DOI
- [25]Clerc I Abba Moussa D Vahlas Z Tardito S Oburoglu L Hope TJ Entry of glucose- and glutamine-derived carbons into the citric acid cycle supports early steps of HIV-1 infection in CD4 T cells. Nat Metab (2019) 1: 717–30. 10.1038/s42255-019-0084-1 PMC7199465 32373781 · DOI
- [26]Datta PK Deshmane S Khalili K Merali S Gordon JC Fecchio C Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr. Cell Cycle (2016) 15: 2288–98. 10.1080/15384101.2016.1190054 PMC5004675 27245560 · DOI
- [27]Loisel-Meyer S Swainson L Craveiro M Oburoglu L Mongellaz C Costa C Glut1-mediated glucose transport regulates HIV infection. Proc Natl Acad Sci USA (2012) 109: 2549–54. 10.1073/pnas.1121427109 PMC3289356 22308487 · DOI
- [28]Palmer CS Ostrowski M Gouillou M Tsai L Yu D Zhou J Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. Aids (2014) 28: 297– 309. 10.1097/qad.0000000000000128 24335483 PMC4293200 · DOI
- [29]Eisenreich W Rudel T Heesemann J Goebel W How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication. Front Cell Infect Microbiol (2019) 9: 42. 10.3389/fcimb.2019.00042 30886834 PMC6409310 · DOI
- [30]Heaton NS Randall G Dengue Virus-induced autophagy regulates lipid metabolism. Cell Host Microbe (2010) 8: 422–32. 10.1016/j.chom.2010.10.006 PMC3026642 21075353 · DOI
- [31]Daniels BP Kofman SB Smith JR Norris GT Snyder AG Kolb JP The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons. Immunity (2019) 50: 64– 76.e64. 10.1016/j.immuni.2018.11.017 30635240 PMC6342485 · DOI
- [32]de Sousa JR Azevedo R Quaresma JAS Vasconcelos P Cell death and Zika virus: An integrated network of the mechanisms of cell injury. Infect Drug Resist (2019) 12: 2917–21. 10.2147/IDR.S209213 PMC6750865 31571944 · DOI
- [33]Jiao H Wachsmuth L Kumari S Schwarzer R Lin J Eren RO Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation. Nature (2020) 580: 391–5. 10.1038/s41586-020-2129-8 PMC7279955 32296175 · DOI
- [34]Newton K Multitasking kinase RIPK1 regulates cell death and inflammation. Cold Spring Harb Perspect Biol (2020) 12: a036368. 10.1101/cshperspect.a036368 31427374 PMC7050590 · DOI
- [35]Kole AJ Annis RP Deshmukh M Mature neurons: equipped for survival. Cell Death Dis (2013) 4: e689–9. 10.1038/cddis.2013.220 PMC3702294 23807218 · DOI
- [36]Diamond DL Syder AJ Jacobs JM Sorensen CM Walters K-A Proll SC Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog (2010) 6: e1000719. 10.1371/journal.ppat.1000719 20062526 PMC2796172 · DOI
- [37]Vastag L Koyuncu E Grady SL Shenk TE Rabinowitz JD Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PloS Pathog (2011) 7: e1002124. 10.1371/journal.ppat.1002124 21779165 PMC3136460 · DOI
- [38]Johnston C Corey L Current concepts for genital Herpes Simplex Virus infection: Diagnostics and pathogenesis of genital tract shedding. Clin Microbiol Rev (2016) 29: 149–61. 10.1128/cmr.00043-15 PMC4771215 26561565 · DOI
- [39]Piccaluga PP Weber A Ambrosio MR Ahmed Y Leoncini L Epstein-Barr virus-induced metabolic rearrangements in human B-cell lymphomas. Front Microbiol (2018) 9: 1233. 10.3389/fmicb.2018.01233 29937761 PMC6002739 · DOI
- [40]Daker M Bhuvanendran S Ahmad M Takada K Khoo AS Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells. Mol Med Rep (2013) 7: 731–41. 10.3892/mmr.2012.1253 PMC3597460 23292678 · DOI
- [41]Valle-Casuso JC Angin M Volant S Passaes C Monceaux V Mikhailova A Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4+ T Cells and offers an opportunity to tackle infection. Cell Metab (2019) 29: 611– 26.e615. 10.1016/j.cmet.2018.11.015 30581119 · DOI
- [42]Kulkarni MM Ratcliff AN Bhat M Alwarawrah Y Hughes P Arcos J Cellular fatty acid synthase is required for late stages of HIV-1 replication. Retrovirology (2017) 14: 45. 10.1186/s12977-017-0368-z 28962653 PMC5622536 · DOI
- [43]Fritsch SD Weichhart T Effects of interferons and viruses on metabolism. Front Immunol (2016) 7: 630. 10.3389/fimmu.2016.00630 28066439 PMC5174094 · DOI
- [44]González-Navajas JM Lee J David M Raz E Immunomodulatory functions of type I interferons. Nat Rev Immunol (2012) 12: 125–35. 10.1038/nri3133 PMC3727154 22222875 · DOI
- [45]Ivashkiv LB Donlin LT Regulation of type I interferon responses. Nat Rev Immunol (2014) 14: 36– 49. 10.1038/nri3581 24362405 PMC4084561 · DOI
- [46]Johnson HM Noon-Song EN Kemppainen K Ahmed CM Steroid-like signalling by interferons: making sense of specific gene activation by cytokines. Biochem J (2012) 443: 329–38. 10.1042/BJ20112187 PMC3509199 22452815 · DOI
- [47]Liao Z Cimakasky LM Hampton R Nguyen DH Hildreth JE Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses (2001) 17: 1009–19. 10.1089/088922201300343690 11485618 · DOI
- [48]Nguyen DH Hildreth JEK Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol (2000) 74: 3264–72. 10.1128/jvi.74.7.3264-3272.2000 PMC111827 10708443 · DOI
- [49]Li C Deng YQ Wang S Ma F Aliyari R Huang XY 25-Hydroxycholesterol protects host against zika virus infection and its associated microcephaly in a mouse model. Immunity (2017) 46: 446–56. 10.1016/j.immuni.2017.02.012 PMC5957489 28314593 · DOI
- [50]Ng CG Coppens I Govindarajan D Pisciotta J Shulaev V Griffin DE Effect of host cell lipid metabolism on alphavirus replication, virion morphogenesis, and infectivity. Proc Natl Acad Sci (2008) 105: 16326. 10.1073/pnas.0808720105 18845681 PMC2571027 · DOI
- [51]Liu SY Aliyari R Chikere K Li G Marsden MD Smith JK Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity (2013) 38: 92– 105. 10.1016/j.immuni.2012.11.005 23273844 PMC3698975 · DOI · Paper page
- [52]Pulliam L Calosing C Sun B Grunfeld C Rempel H Monocyte activation from interferon-α in HIV infection increases acetylated LDL uptake and ROS production. J Interferon Cytokine Res (2014) 34: 822–8. 10.1089/jir.2013.0152 PMC4186262 24731171 · DOI
- [53]Mellor AL Munn DH Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today (1999) 20: 469–73. 10.1016/S0167-5699(99)01520-0 10500295 · DOI
- [54]Mellor AL Keskin DB Johnson T Chandler P Munn DH Cells expressing Indoleamine 2,3-Dioxygenase inhibit T cell responses. J Immunol (2002) 168: 3771–6. 10.4049/jimmunol.168.8.3771 11937528 · DOI
- [55]Adams O Besken K Oberdörfer C MacKenzie CR Takikawa O Däubener W Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J Virol (2004) 78: 2632–6. 10.1128/jvi.78.5.2632-2636.2004 PMC369218 14963171 · DOI
- [56]Bodaghi B Goureau O Zipeto D Laurent L Virelizier J-L Michelson S Role of IFN-γ-Induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of Human Cytomegalovirus in retinal pigment epithelial cells. J Immunol (1999) 162: 957–64. 9916720
- [57]Rabbani MAG Barik S 5-Hydroxytryptophan, a major product of tryptophan degradation, is essential for optimal replication of human parainfluenza virus. Virology (2017) 503: 46– 51. 10.1016/j.virol.2017.01.007 28113063 PMC5478882 · DOI
- [58]Adams O Besken K Oberdörfer C MacKenzie CR Rüssing D,WD Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect (2004) 6: 806–12. 10.1016/j.micinf.2004.04.007 15374002 · DOI
- [59]Jagannathan-Bogdan M McDonnell ME Shin H Rehman Q Hasturk H Apovian CM Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol (2011) 186: 1162–72. 10.4049/jimmunol.1002615 PMC3089774 21169542 · DOI
- [60]Sireesh D Dhamodharan U Ezhilarasi K Vijay V Ramkumar KM Association of NF-E2 Related Factor 2 (Nrf2) and inflammatory cytokines in recent onset Type 2 Diabetes Mellitus. Sci Rep (2018) 8: 5126. 10.1038/s41598-018-22913-6 29572460 PMC5865120 · DOI
- [61]Zeng C Shi X Zhang B Liu H Zhang L Ding W The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (2012) 90: 175–86. 10.1007/s00109-011-0816-5 21964948 · DOI
- [62]Kiselar JG Wang X Dubyak GR El Sanadi C Ghosh SK Lundberg K Modification of β-Defensin-2 by Dicarbonyls Methylglyoxal and Glyoxal inhibits antibacterial and chemotactic function in vitro. PLoS One (2015) 10: e0130533. 10.1371/journal.pone.0130533 26244639 PMC4526640 · DOI
- [63]Joshi MB Lad A Bharath Prasad AS Balakrishnan A Ramachandra L Satyamoorthy K High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation. FEBS Lett (2013) 587: 2241–6. 10.1016/j.febslet.2013.05.053 23735697 · DOI
- [64]Nelson CP Hindson DA Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes (1989) 38: 1031–5. 10.2337/diab.38.8.1031 2753233 · DOI
- [65]Perner A Nielsen SE Rask-Madsen J High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med (2003) 29: 642–5. 10.1007/s00134-002-1628-4 12552364 · DOI
- [66]Jafar N Edriss H Nugent K The effect of short-Term hyperglycemia on the innate immune system. Am J Med Sci (2016) 351: 201–11. 10.1016/j.amjms.2015.11.011 26897277 · DOI
- [67]Stegenga ME van der Crabben SN Blümer RME Levi M Meijers JCM Serlie MJ Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood (2008) 112: 82–9. 10.1182/blood-2007-11-121723 PMC2435690 18316629 · DOI
- [68]Kanafani ZA Kourany WM Fowler VG Levine DP Vigliani GA Campion M Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. Eur J Clin Microbiol Infect Dis (2009) 28: 1477. 10.1007/s10096-009-0808-3 19730900 · DOI
- [69]Yang X Yu Y Xu J Shu H Xia J Liu H Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med (2020) 8: 475–81. 10.1016/S2213-2600(20)30079-5 PMC7102538 32105632 · DOI · Paper page
- [70]Zhou F Yu T Du R Fan G Liu Y Liu Z Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (2020) 395: 1054–62. 10.1016/S0140-6736(20)30566-3 PMC7270627 32171076 · DOI · Paper page
- [71]Muniangi-Muhitu H Akalestou E Salem V Misra S Oliver NS Rutter GA Covid-19 and diabetes: A complex bidirectional relationship. Front Endocrinol (2020) 11: 582936. 10.3389/fendo.2020.582936 PMC7578412 33133024 · DOI
- [72]Lim S Bae JH Kwon H-S Nauck MA COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol (2021) 17: 11– 30. 10.1038/s41574-020-00435-4 33188364 PMC7664589 · DOI
- [73]Fleming DM Crombie DL Cross KW Disease concurrence in diabetes mellitus: a study of concurrent morbidity over 12 months using diabetes mellitus as an example. J Epidemiol Community Health (1991) 45: 73–7. 10.1136/jech.45.1.73 PMC1060706 2045750 · DOI
- [74]Lenzi L ÂMM Silva L Grochocki M Pontarolo R Pandemic influenza A (H1N1) 2009: risk factors for hospitalization. J Bras Pneumol (2012) 38: 57– 65. 10.1590/S1806-37132012000100009 22407041 · DOI
- [75]Allard R Leclerc P Tremblay C Tannenbaum T-N Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care (2010) 33: 1491–3. 10.2337/dc09-2215 PMC2890346 20587722 · DOI
- [76]Louie JK Acosta M Winter K Jean C Gavali S Schechter R Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California. JAMA (2009) 302: 1896–902. 10.1001/jama.2009.1583 19887665 · DOI
- [77]Abdi A Jalilian M Sarbarzeh PA Vlaisavljevic Z Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Res Clin (2020) 166: 108347. 10.1016/j.diabres.2020.108347 PMC7375314 32711003 · DOI
- [78]Azar WS Njeim R Fares AH Azar NS Azar ST El Sayed M COVID-19 and diabetes mellitus: how one pandemic worsens the other. Rev Endocr Metab Disord (2020) 21: 451–63. 10.1007/s11154-020-09573-6 PMC7395898 32743793 · DOI
- [79]de Siqueira JVV Almeida LG Zica BO Brum IB Barceló A de Siqueira Galil AG Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review. Obes Res Clin Pract (2020) 14: 398– 403. 10.1016/j.orcp.2020.07.005 32736969 PMC7377684 · DOI
- [80]Popkin BM Du S Green WD Beck MA Algaith T Herbst CH Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev (2020) 21: e13128. 10.1111/obr.13128 32845580 PMC7461480 · DOI · Paper page
- [81]Wu J Zhang F Fang F Chang H Wang F Yang Z Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes. Vaccine (2010) 28: 2775–81. 10.1016/j.vaccine.2010.01.037 20117261 · DOI
- [82]Reading PC Allison J Crouch EC Anders EM Increased susceptibility of diabetic mice to Influenza virus infection: Compromise of collectin-mediated host defense of the lung by glucose? J Virol (1998) 72: 6884–7. 10.1128/jvi.72.8.6884-6887.1998 PMC109899 9658139 · DOI
- [83]Huo C Zhang S Zhang S Wang M Qi P Xiao J Mice with type 1 diabetes exhibit increased susceptibility to influenza A virus. Microb Pathog (2017) 113: 233–41. 10.1016/j.micpath.2017.10.026 29066377 · DOI
- [84]Guan W-j Ni Z-y Hu Y Liang W-h Ou C-q He J-x Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med (2020) 382: 1708–20. 10.1056/NEJMoa2002032 PMC7092819 32109013 · DOI · Paper page
- [85]Simonnet A Chetboun M Poissy J Raverdy V Noulette J Duhamel A High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (2020). 28: 1195–99. 10.1002/oby.22831. n/a. PMC7262326 32271993 · DOI
- [87]Konoshita T Wakahara S Mizuno S Motomura M Aoyama C Makino Y Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care (2006) 29: 848–52. 10.2337/diacare.29.04.06.dc05-1873 16567826 · DOI
- [88]Mizuri S Aoki T Hemmi H Arita M Sakai K Aikawa A Urinary angiotensin-converting enzyme 2 in patients with CKD. Nephrology (2011) 16: 567–72. 10.1111/j.1440-1797.2011.01467.x 21457402 · DOI
- [89]Ferrario CM Jessup J Gallagher PE Averill DB Brosnihan KB Ann Tallant E Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int (2005) 68: 2189–96. 10.1111/j.1523-1755.2005.00675.x 16221218 · DOI
- [90]Furuhashi M Moniwa N Mita T Fuseya T Ishimura S Ohno K Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker. Am J Hypertens (2015) 28: 15– 21. 10.1093/ajh/hpu086 24842388 · DOI
- [91]Roca-Ho H Riera M Palau V Pascual J Soler MJ Characterization of ACE and ACE2 expression within different organs of the NOD mouse. Int J Mol Sci (2017) 18: 563. 10.3390/ijms18030563 PMC5372579 28273875 · DOI
- [92]Wysocki J Garcia-Halpin L Ye M Maier C Sowers K Burns KD Regulation of urinary ACE2 in diabetic mice. Am J Physiol Renal Physiol (2013) 305: F600–611. 10.1152/ajprenal.00600.2012 PMC3891267 23761674 · DOI
- [93]Monteil V Kwon H Prado P Hagelkrüys A Wimmer RA Stahl M Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell Chem Biol (2020) 181: 905–13. 10.1016/j.cell.2020.04.004 PMC7181998 32333836 · DOI · Paper page
- [95]Chung S-C Providencia R Sofat R Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom. N Engl J Med (2020) 383: 397– 400. 10.1056/NEJMc2005396 32383830 PMC7233186 · DOI
- [96]Fedson DS Treating influenza with statins and other immunomodulatory agents. Antiviral Res (2013) 99: 417–35. 10.1016/j.antiviral.2013.06.018 23831494 · DOI
- [97]Yang P Gu H Zhao Z Wang W Cao B Lai C Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep (2014) 4: 7027. 10.1038/srep07027 25391767 PMC4229671 · DOI · Paper page
- [98]Yang JK Feng Y Yuan MY Yuan SY Fu HJ Wu BY Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabetic Med (2006) 23: 623–8. 10.1111/j.1464-5491.2006.01861.x 16759303 · DOI
- [99]Alqahtani FY Aleanizy FS Mohamed RAEH Alanazi MS Mohamed N Alrasheed MM Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study. Epidemiol Infect (2018) 147: e35. 10.1017/S0950268818002923 PMC6518603 30394248 · DOI
- [100]Kulcsar KA Coleman CM Beck SE Frieman MB Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight (2019) 4: e131774. 10.1172/jci.insight.131774 PMC6824443 31550243 · DOI
- [101]Yang J-K Lin S-S Ji X-J Guo L-M Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol (2010) 47: 193–9. 10.1007/s00592-009-0109-4 PMC7088164 19333547 · DOI
- [102]Fignani D Licata G Brusco N Nigi L Grieco GE Marselli L SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature. Front Endocrinol (2020) 11: 596898. 10.3389/fendo.2020.596898 PMC7691425 33281748 · DOI
- [103]Esaki S Yamano K Kiguchi J Katsumi S Keceli S Okamoto H Diabetic mice show an aggravated course of herpes-simplex virus-induced facial nerve paralysis. Otol Neurotol (2012) 33: 1452–7. 10.1097/MAO.0b013e318268d54d 22931869 · DOI
- [104]McCormick D Herpes-simplex Virus as a cause of Bell’s Palsy. Lancet (1972) 299: 937–9. 10.1016/S0140-6736(72)91499-7 4112101 · DOI
- [105]Okamoto S Hata A Sadaoka K Yamanishi K Mori Y Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis (2009) 200: 1606–10. 10.1086/644646 19821719 · DOI
- [106]Mehta SH Moore RD Thomas DL Chaisson RE Sulkowski MS The Effect of HAART and HCV Infection on the Development of Hyperglycemia Among HIV-Infected Persons. J Acquir Immune Defic Syndr (2003) 33: 577–84. 10.1097/00126334-200308150-00005 12902801 · DOI
- [107]Brown TT Cole SR Li X Kingsley LA Palella FJ Riddler SA Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med (2005) 165: 1179–84. 10.1001/archinte.165.10.1179 15911733 · DOI
- [108]Hresko RC Hruz PW HIV Protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4. PloS One (2011) 6: e25237. 10.1371/journal.pone.0025237 21966466 PMC3179492 · DOI
- [109]Carr A HIV Protease Inhibitor-Related Lipodystrophy Syndrome. Clin Infect Dis (2000) 30: S135–42. 10.1086/313854 10860898 · DOI
- [110]Zhang S Carper MJ Lei X Cade WT Yarasheski KE Ramanadham S Protease inhibitors used in the treatment of HIV+ induce β-cell apoptosis via the mitochondrial pathway and compromise insulin secretion. Am J Physiol Endocrinol Metab (2009) 296: E925–35. 10.1152/ajpendo.90445.2008 PMC2670620 19208856 · DOI
- [111]Koster JC Remedi MS Qiu H Nichols CG Hruz PW HIV Protease inhibitors acutely impair glucose-stimulated insulin release. Diabetes (2003) 52: 1695–700. 10.2337/diabetes.52.7.1695 PMC1403824 12829635 · DOI
- [112]Maier HE Lopez R Sanchez N Ng S Gresh L Ojeda S Obesity increases the duration of influenza A virus shedding in adults. J Infect Dis (2018) 218: 1378–82. 10.1093/infdis/jiy370 PMC6151083 30085119 · DOI · Paper page
- [113]O’Brien KB Vogel P Duan S Govorkova EA Webby RJ McCullers JA Impaired wound healing predisposes obese mice to severe influenza virus infection. J Infect Dis (2012) 205: 252–61. 10.1093/infdis/jir729 PMC3244366 22147799 · DOI
- [114]Honce R Schultz-Cherry S Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution. Front Immunol (2019) 10: 1071. 10.3389/fimmu.2019.01071 31134099 PMC6523028 · DOI
- [115]Sheridan PA Paich HA Handy J Karlsson EA Hudgens MG Sammon AB Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (2012) 36: 1072–7. 10.1038/ijo.2011.208 PMC3270113 22024641 · DOI
- [116]Morgan OW Bramley A Fowlkes A Freedman DS Taylor TH Gargiullo P Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease. PLoS One (2010) 5: e9694. 10.1371/journal.pone.0009694 20300571 PMC2837749 · DOI
- [117]Yu H Feng Z Uyeki TM Liao Q Zhou L Feng L Risk factors for severe illness with 2009 pandemic Influenza A (H1N1) virus infection in China. Clin Infect Dis (2011) 52: 457–65. 10.1093/cid/ciq144 PMC3060897 21220768 · DOI
- [118]Cai Q Chen F Wang T Luo F Liu X Wu Q Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care (2020). 43: 1392–98. 10.2337/dc20-0576 32409502 · DOI
- [119]Al-Benna S Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med (2020) 19: 100283–3. 10.1016/j.obmed.2020.100283 PMC7368415 32835126 · DOI
- [120]Ryan PM Caplice NM Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019? Obes (Silver Spring) (2020) 28: 1191–4. 10.1002/oby.22843 PMC7264526 32314868 · DOI
- [122]Weitman ES Aschen SZ Farias-Eisner G Albano N Cuzzone DA Ghanta S Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS One (2013) 8: e70703. 10.1371/journal.pone.0070703 23950984 PMC3741281 · DOI
- [124]Yang H Youm Y-H Vandanmagsar B Rood J Kumar KG Butler AA Obesity accelerates thymic aging. Blood (2009) 114: 3803–12. 10.1182/blood-2009-03-213595 PMC2773495 19721009 · DOI
- [125]Rebeles J Green WD Alwarawrah Y Nichols AG Eisner W Danzaki K Obesity-induced changes in T-cell metabolism are associated with impaired memory T-cell response to influenza and are not reversed with weight loss. J Infect Dis (2018) 219: 1652–61. 10.1093/infdis/jiy700 PMC6473176 30535161 · DOI
- [126]Sinha RA Singh BK Yen PM Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol (2018) 14: 259–69. 10.1038/nrendo.2018.10 PMC6013028 29472712 · DOI
- [127]Castillo M Hall JA Correa-Medina M Ueta C Kang HW Cohen DE Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes (2011) 60: 1082–9. 10.2337/db10-0758 PMC3064082 21335378 · DOI
- [129]Ajavon A Killian D Odom R Figliozzi RW Chen F Balish M Influence of thyroid hormone disruption on the incidence of shingles. Epidemiol Infect (2015) 143: 3557–71. 10.1017/s0950268815000655 PMC4618279 26189668 · DOI
- [130]Hsia SV Chen LH Tseng HF Receipt of thyroid hormone deficiency treatment and risk of herpes zoster. Int J Infect Dis (2017) 59: 90–5. 10.1016/j.ijid.2017.04.016 PMC5497494 28450196 · DOI
- [131]Bedadala GR Pinnoji RC Palem JR Hsia S-CV Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells. Cell Res (2010) 20: 587–98. 10.1038/cr.2010.50 PMC2862894 20386570 · DOI
- [132]Dossetor J Whittle HC Greenwood BM Persistent measles infection in malnourished children. Br Med J (1977) 1: 1633–5. 10.1136/bmj.1.6077.1633 PMC1607735 871699 · DOI
- [133]Tupasi TE Lucero MG Magdangal DM Mangubat NV Sunico ME Torres CU Etiology of acute lower respiratory tract infection in children from Alabang, Metro Manila. Rev Infect Dis (1990) 12 Suppl 8: S929–39. 10.1093/clinids/12.supplement_8.s929 2270415 · DOI
- [134]Darmanin S Chen J Zhao S Cui H Shirkoohi R Kubo N All-trans Retinoic Acid Enhances Murine Dendritic Cell Migration to Draining Lymph Nodes via the Balance of Matrix Metalloproteinases and Their Inhibitors. J Immunol (2007) 179: 4616. 10.4049/jimmunol.179.7.4616 17878359 · DOI
- [135]Geissmann F Revy P Brousse N Lepelletier Y Folli C Durandy A Retinoids regulate survival and antigen presentation by immature dendritic cells. J Exp Med (2003) 198: 623–34. 10.1084/jem.20030390 PMC2194172 12925678 · DOI
- [136]Lu L Lan Q Li Z Zhou X Gu J Li Q Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA (2014) 111: E3432–40. 10.1073/pnas.1408780111 PMC4143025 25099355 · DOI
- [137]Jaggi U Varanasi SK Bhela S Rouse BT On the role of retinoic acid in virus induced inflammatory response in cornea. Microbes Infect (2018) 20: 337–45. 10.1016/j.micinf.2018.04.007 29842984 · DOI
- [138]Butler JC Havens PL Day SE Chusid MJ Sowell AL Huff DL Measles severity and serum retinol (Vitamin A) concentration among children in the United States. Pediatrics (1993) 91: 1176–81. 8502524
- [139]Coutsoudis A Broughton M Coovadia HM Vitamin A supplementation reduces measles morbidity in young African children: a randomized, placebo-controlled, double-blind trial. Am J Clin Nutr (1991) 54: 890–5. 10.1093/ajcn/54.5.890 1951162 · DOI
- [140]Coutsoudis A Kiepiela P Coovadia HM Broughton M Vitamin A supplementation enhances specific IgG antibody levels and total lymphocyte numbers while improving morbidity in measles. Pediatr Infect Dis J (1992) 11: 203–9. 10.1097/00006454-199203000-00006 1565535 · DOI
- [141]Myles IA Fontecilla NM Janelsins BM Vithayathil PJ Segre JA Datta SK Parental dietary fat intake alters offspring microbiome and immunity. J Immunol (2013) 191: 3200–9. 10.4049/jimmunol.1301057 PMC3831371 23935191 · DOI
- [142]Milner JJ Rebeles J Dhungana S Stewart DA Sumner SCJ Meyers MH Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice. J Immunol (2015) 194: 4846–59. 10.4049/jimmunol.1402295 PMC4417391 25862817 · DOI
- [143]Kim JY Lim K Kim KH Kim JH Choi JS Shim S-C. N-3 polyunsaturated fatty acids restore Th17 and Treg balance in collagen antibody-induced arthritis. PLoS One (2018) 13: e0194331. 10.1371/journal.pone.0194331 29543869 PMC5854360 · DOI
- [144]Innes JK Calder PC Omega-6 fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids (2018) 132: 41–8. 10.1016/j.plefa.2018.03.004 29610056 · DOI
- [145]Schwerbrock NMJ Karlsson EA Shi Q Sheridan PA Beck MA Fish oil-fed mice have impaired resistance to influenza infection. J Nutr (2009) 139: 1588–94. 10.3945/jn.109.108027 PMC2709305 19549756 · DOI
- [146]Antunes KH Fachi JL de Paula R da Silva EF Pral LP dos Santos AÁ Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun (2019) 10: 3273. 10.1038/s41467-019-11152-6 31332169 PMC6646332 · DOI
- [147]Trompette A Gollwitzer ES Pattaroni C Lopez-Mejia IC Riva E Pernot J Dietary fiber confers protection against Flu by shaping Ly6c– patrolling Monocyte hematopoiesis and CD8+ T cell metabolism. Immunity (2018) 48: 992– 1005.e1008. 10.1016/j.immuni.2018.04.022 29768180 · DOI · Paper page
- [149]Sumbria D Berber E Rouse BT Supplementing the diet with sodium propionate suppresses the severity of viral immuno-inflammatory lesions. J Virol (2020) 95: e02056–20. 10.1128/JVI.02056-20. VI.02056-02020. PMC7851545 33208449 · DOI
- [150]Uyangaa E Lee H-K Eo SK Glutamine and leucine provide enhanced protective immunity against mucosal infection with herpes simplex virus type 1. Immune Netw (2012) 12: 196– 206. 10.4110/in.2012.12.5.196 23213313 PMC3509164 · DOI
- [151]Wang K Hoshino Y Dowdell K Bosch-Marce M Myers TG Sarmiento M Glutamine supplementation suppresses herpes simplex virus reactivation. J Clin Investig (2017) 127: 2626–30. 10.1172/JCI88990 PMC5490748 28581445 · DOI
- [152]Sencio V Barthelemy A Tavares LP Machado MG Soulard D Cuinat C Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Rep (2020) 30: 2934– 47.e2936. 10.1016/j.celrep.2020.02.013 32130898 · DOI
- [153]Moriyama M Ichinohe T High ambient temperature dampens adaptive immune responses to influenza A virus infection. Proc Natl Acad Sci USA (2019) 116: 3118–25. 10.1073/pnas.1815029116 PMC6386664 30718396 · DOI
- [154]Sanchez EL Pulliam TH Dimaio TA Thalhofer AB Delgado T Lagunoff M Glycolysis, glutaminolysis, and fatty acid synthesis are required for distinct stages of kaposi’s sarcoma-associated herpesvirus lytic replication. J Virol (2017) 91: e02237–02216. 10.1128/jvi.02237-16 PMC5411582 28275189 · DOI
- [155]Boodhoo N Kamble N Kaufer BB Behboudi S Targeted induction of de novo Fatty acid synthesis enhances MDV replication in a COX-2/PGE2α dependent mechanism through EP2 and EP4 receptors engagement. bioRxiv (2018), 323840. 10.1101/323840 · DOI
- [156]Greseth MD Traktman P De novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infection. PLoS Pathog (2014) 10: e1004021. 10.1371/journal.ppat.1004021 24651651 PMC3961357 · DOI
- [157]Zhang N Zhao H Zhang L Fatty acid synthase promotes the palmitoylation of Chikungunya Virus nsP1. J Virol (2019) 93: e01747–01718. 10.1128/jvi.01747-18 PMC6340048 30404808 · DOI
- [158]Martín-Acebes MA Blázquez A-B Jiménez de Oya N Escribano-Romero E Saiz J-C West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS One (2011) 6: e24970. 10.1371/journal.pone.0024970 21949814 PMC3176790 · DOI
- [159]Merino-Ramos T Vázquez-Calvo Á Casas J Sobrino F Saiz J-C Martín-Acebes MA Modification of the host cell lipid metabolism induced by hypolipidemic drugs targeting the Acetyl Coenzyme A Carboxylase impairs West Nile virus replication. Antimicrob Agents Chemother (2016) 60: 307–15. 10.1128/aac.01578-15 PMC4704205 26503654 · DOI
- [160]Fernandes-Siqueira LO Zeidler JD Sousa BG Ferreira T Da Poian AT Anaplerotic role of glucose in the oxidation of endogenous fatty acids during dengue virus infection. mSphere (2018) 3: e00458–00417. 10.1128/mSphere.00458-17 PMC5793041 29404419 · DOI
- [161]Kohio HP Adamson AL Glycolytic control of vacuolar-type ATPase activity: A mechanism to regulate influenza viral infection. Virology (2013) 444: 301–9. 10.1016/j.virol.2013.06.026 23876457 · DOI
- [162]Kulkarni A Mateus M Thinnes CC McCullagh JS Schofield CJ Taylor GP Glucose metabolism and oxygen availability govern reactivation of the latent human retrovirus HTLV-1. Cell Chem Biol (2017) 24: 1377– 87.e1373. 10.1016/j.chembiol.2017.08.016 28965728 PMC5696563 · DOI
- [163]Gualdoni GA Mayer KA Kapsch A-M Kreuzberg K Puck A Kienzl P Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication. Proc Natl Acad Sci USA (2018) 115: E7158–65. 10.1073/pnas.1800525115 PMC6065033 29987044 · DOI
- [164]Cinatl J Vogel J-U Cinatl J Kabickova H Kornhuber B Doerr HW Antiviral effects of 6-diazo-5-oxo-l-norleucin on replication of herpes simplex virus type 1. Antiviral Res (1997) 33: 165–75. 10.1016/S0166-3542(96)01012-1 9037373 · DOI
- [165]Nishio M Tsurudome M Bando H Komada H Ito Y Antiviral Effect of 6-diazo-5-oxo-l-Norleucine, Antagonist of γ-glutamyl Transpeptidase, on Replication of Human Parainfluenza Virus Type 2. J Gen Virol (1990) 71: 61–7. 10.1099/0022-1317-71-1-61 1968085 · DOI
- [166]Huang RC Panin M Romito RR Huang YT Inhibition of replication of human respiratory syncytial virus by 6-diazo-5-oxo-l-norleucine. Antiviral Res (1994) 25: 269–79. 10.1016/0166-3542(94)90009-4 7710273 · DOI
- [167]Wang A Huen SC Luan HH Yu S Zhang C Gallezot J-D Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation. Cell Chem Biol (2016) 166: 1512– 25.e151. 10.1016/j.cell.2016.07.026 PMC5555589 27610573 · DOI · Paper page
- [168]Varanasi SK Donohoe D Jaggi U Rouse BT Manipulating glucose metabolism during different stages of viral pathogenesis can have either detrimental or beneficial effects. J Immunol (2017) 199: 1748–61. 10.4049/jimmunol.1700472 PMC5584583 28768727 · DOI
- [169]Jiménez de Oya N Esler WP Huard K El-Kattan AF Karamanlidis G Blázquez A-B Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models. Emerg Microbes Infect (2019) 8: 624–36. 10.1080/22221751.2019.1604084 PMC6493301 30999821 · DOI
- [170]Barzon L Pacenti M Palù G West Nile virus and kidney disease. Expert Rev Anti Infect Ther (2013) 11: 479–87. 10.1586/eri.13.34 23627854 · DOI
- [171]Manivannan S Baxter VK Schultz KLW Slusher BS Griffin DE Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis. J Virol (2016) 90: 9251–62. 10.1128/jvi.01045-16 PMC5044826 27489275 · DOI
Cited by
Sorted by citations
Kuchemüller, K. B., Austerjost, J., Machleid, R., Roßkamp, A., Niemann, J., & McCready, C. (2026) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-026-03362-2
- Authors
- Sumbria, D., Berber, E., Mathayan, M., & Rouse, B. T.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-03
- Volume
- 11
- ISSN
- 1664-3224
- PMC
- PMC7887310
- Cited by
- 141
- References
- 6
- Funders
- National Institutes of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review